bluebird bio, Inc. Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in bluebird bio, Inc. for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Option Exercise | M | 25.16 | 1,050 | 26,418 | 4,500 | |
| Feb 17 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 80.22 | 1,050 | 84,235 | 1,000 | 2.1 K to 1,000 (-51.22 %) |
| Feb 17 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Buy | M | 25.16 | 1,050 | 26,418 | 2,050 | 1,000 to 2.1 K (+105.00 %) |
| Feb 17 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 150 | 313 | 22,508 | |
| Feb 17 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 80.22 | 150 | 12,034 | 1,400 | 1.6 K to 1.4 K (-9.68 %) |
| Feb 17 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 150 | 313 | 1,550 | 1.4 K to 1.6 K (+10.71 %) |
| Feb 17 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 80.22 | 666 | 53,429 | 12,051 | 12.7 K to 12.1 K (-5.24 %) |
| Feb 16 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Option Exercise | M | 25.16 | 1,950 | 49,062 | 5,550 | |
| Feb 16 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Option Exercise | M | 21.43 | 4,000 | 85,720 | 0 | |
| Feb 16 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 80.01 | 5,950 | 476,076 | 1,000 | 7 K to 1,000 (-85.61 %) |
| Feb 16 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Buy | M | 25.16 | 1,950 | 49,062 | 6,950 | 5 K to 7 K (+39.00 %) |
| Feb 16 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Buy | M | 21.43 | 4,000 | 85,720 | 5,000 | 1,000 to 5 K (+400.00 %) |
| Feb 16 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 850 | 1,773 | 22,658 | |
| Feb 16 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 80.01 | 850 | 68,011 | 1,400 | 2.3 K to 1.4 K (-37.78 %) |
| Feb 16 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 850 | 1,773 | 2,250 | 1.4 K to 2.3 K (+60.71 %) |
| Feb 16 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 80.01 | 3,772 | 301,808 | 12,717 | 16.5 K to 12.7 K (-22.88 %) |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | A | 75.60 | 58,300 | 4,407,480 | 58,300 | |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Grant | A | 0.00 | 14,600 | 0 | 27,305 | 12.7 K to 27.3 K (+114.92 %) |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | A | 75.60 | 34,100 | 2,577,960 | 34,100 | |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Grant | A | 0.00 | 8,500 | 0 | 37,779 | 29.3 K to 37.8 K (+29.03 %) |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | D | 2.09 | 2,000 | 4,180 | 23,239 | |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | A | 75.60 | 34,100 | 2,577,960 | 34,100 | |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 74.51 | 1,130 | 84,197 | 17,177 | 18.3 K to 17.2 K (-6.17 %) |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 73.55 | 870 | 63,991 | 18,307 | 19.2 K to 18.3 K (-4.54 %) |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 2.09 | 2,000 | 4,180 | 19,177 | 17.2 K to 19.2 K (+11.64 %) |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Grant | A | 0.00 | 8,500 | 0 | 17,177 | 8.7 K to 17.2 K (+97.96 %) |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | A | 75.60 | 28,500 | 2,154,600 | 28,500 | |
| Feb 03 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Grant | A | 0.00 | 7,100 | 0 | 16,489 | 9.4 K to 16.5 K (+75.62 %) |
| Feb 02 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Option Exercise | M | 21.43 | 8,000 | 171,440 | 4,000 | |
| Feb 02 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 75.04 | 8,000 | 600,322 | 1,000 | 9 K to 1,000 (-88.89 %) |
| Feb 02 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Buy | M | 21.43 | 8,000 | 171,440 | 9,000 | 1,000 to 9 K (+800.00 %) |